XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.20.1

Revenue from contracts with customers (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2020
Summary of disaggregates revenues by major revenue streams | The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.
|  | Three months ended March 31, 2020 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 1,625 |  |  |  | 1,370 |  |  |  | 482 |  |  |  | 177 |  |  |  | 3,655 |
Licensing arrangements |  |  | 25 |  |  |  | 12 |  |  |  | 3 |  |  |  | 1 |  |  |  | 41 |
Distribution |  |  | 426 |  |  |  | 2 |  |  |  | 6 |  |  |  | — |  |  |  | 434 |
Other |  |  | 6 |  |  |  | 19 |  |  |  | 74 |  |  |  | 129 |  |  |  | 227 |
|  | $ | 2,082 |  |  | $ | 1,402 |  |  | $ | 565 |  |  | $ | 307 |  |  | $ | 4,357 |
|  | Three months ended March 31, 2019 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of g oods |  |  | 1,637 |  |  |  | 1,259 |  |  |  | 468 |  |  |  | 187 |  |  |  | 3,551 |
Licensing arrangements |  |  | 31 |  |  |  | 5 |  |  | § |  |  |  |  | 1 |  |  |  | 37 |
Distribution |  |  | 379 |  |  | § |  |  |  |  | 5 |  |  |  | — |  |  |  | 383 |
Other |  |  | — |  |  | § |  |  |  |  | 48 |  |  |  | 128 |  |  |  | 176 |
|  | $ | 2,047 |  |  | $ | 1,264 |  |  | $ | 521 |  |  | $ | 317 |  |  | $ | 4,149 |
§ | Represents an amount less than $1 million.
Summary of Sales Reserves and Allowances | The changes in SR&A for third-party sales for the three months ended March 31, 2020 and 2019 were as follows:
|  | Sales Reserves and Allowances |  |  |  |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in SR&A |  |  | Total |
|  | (U.S. $ in millions) |
Balance at December 31, 2019 |  | $ | 87 |  |  | $ | 2,895 |  |  | $ | 1,109 |  |  | $ | 1,342 |  |  | $ | 637 |  |  | $ | 176 |  |  | $ | 6,159 |  |  | $ | 6,246 |
Provisions related to sales made in current year period |  |  | 102 |  |  |  | 1,370 |  |  |  | 233 |  |  |  | 2,223 |  |  |  | 139 |  |  |  | 33 |  |  |  | 3,998 |  |  |  | 4,100 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | (106 | ) |  |  | (29 | ) |  |  | (16 | ) |  |  | (1 | ) |  |  | 4 |  |  |  | (148 | ) |  |  | (148 | )
Credits and payments |  |  | (106 | ) |  |  | (1,513 | ) |  |  | (248 | ) |  |  | (2,396 | ) |  |  | (112 | ) |  |  | (35 | ) |  |  | (4,304 | ) |  |  | (4,410 | )
Translation differences |  |  | — |  |  |  | (21 | ) |  |  | (2 | ) |  |  | (6 | ) |  |  | (4 | ) |  |  | (10 | ) |  |  | (43 | ) |  |  | (43 | )
Balance at March 31, 2020 |  | $ | 83 |  |  |  | 2,625 |  |  | $ | 1,063 |  |  | $ | 1,147 |  |  | $ | 659 |  |  | $ | 168 |  |  | $ | 5,662 |  |  | $ | 5,745 |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in SR&A |  |  | Total |
|  | (U.S.$ in millions) |
Balance at December 31, 2018 |  | $ | 175 |  |  | $ | 3,006 |  |  | $ | 1,361 |  |  | $ | 1,530 |  |  | $ | 638 |  |  | $ | 176 |  |  | $ | 6,711 |  |  | $ | 6,886 |
Provisions related to sales made in current year period |  |  | 112 |  |  |  | 1,350 |  |  |  | 324 |  |  |  | 2,320 |  |  |  | 72 |  |  |  | 114 |  |  |  | 4,180 |  |  |  | 4,292 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | (5 | ) |  |  | 3 |  |  |  | (1 | ) |  |  | (2 | ) |  |  | (2 | )
Credits and payments |  |  | (125 | ) |  |  | (1,613 | ) |  |  | (438 | ) |  |  | (2,413 | ) |  |  | (117 | ) |  |  | (101 | ) |  |  | (4,682 | ) |  |  | (4,807 | )
Translation differences |  |  | — |  |  |  | (6 | ) |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | (7 | )
Balance at March 31, 2019 |  | $ | 162 |  |  |  | 2,737 |  |  | $ | 1,247 |  |  | $ | 1,432 |  |  | $ | 596 |  |  | $ | 188 |  |  | $ | 6,200 |  |  | $ | 6,362 |

X
- Definition Tabular disclosure of sales reserves and allowances current. + References No definition available. + Details
Name: | teva_SalesReservesAndAllowancesCurrentTableTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration